R. Scott Wright, MD - Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia Management

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GVK865. CME credit will be available until February 13, 2025.Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia ManagementThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresR. Scott Wright, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Boehringer Ingelheim Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Novo Nordisk Inc.CME ReviewerRamil GoelAssistant Professor of MedicineDivision of Cardiovascular MedicineElectrophysiology SectionUniversity of Florida College of MedicineGainesville, FloridaRamil Goel, MD, FHRS, has no relevant financial relationships to disclose.